A finding that could suggest a possible role of truncating mutations in the TOX gene as regulators of the plasma cell programme, as indicated by the absence of TOX expression in plasma cells and myelomas and the inactivation of this programme in ABC-DLBCL [30]. This evidence concerns the gene TOX and diffuse large B-cell lymphoma.